{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:49:50Z","timestamp":1789008590459,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2019-0324"],"award-info":[{"award-number":["FO2019-0324"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2015-61X-22051-04-4"],"award-info":[{"award-number":["K2015-61X-22051-04-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004961","name":"Instituto Tecnol\u00f3gico y de Estudios Superiores de Monterrey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-930978"],"award-info":[{"award-number":["AF-930978"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["514592"],"award-info":[{"award-number":["514592"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018163","name":"Margareta af Ugglas Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.expneurol.2023.114545","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T17:36:21Z","timestamp":1694972181000},"page":"114545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Low dose of levetiracetam counteracts amyloid \u03b2-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity"],"prefix":"10.1016","volume":"369","author":[{"given":"Arturo G.","family":"Isla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Balleza-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengna","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Fisahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2023.114545_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2019.11.001","article-title":"Gamma entrainment: impact on neurocircuits, glia, and therapeutic opportunities","author":"Adaikkan","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.04.011","article-title":"Gamma entrainment binds higher-order brain regions and offers neuroprotection","volume":"102","author":"Adaikkan","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114545_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13839-6","article-title":"Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer\u2019s disease pathology","volume":"7","author":"Ahnaou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114545_bb0020","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1113\/JP279718","article-title":"Modulation of Kv3.1\/Kv3.2 promotes gamma oscillations by rescuing A\u03b2-induced desynchronization of fast-spiking interneuron firing in an AD mouse model in vitro","volume":"598","author":"Andrade-Talavera","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0025","first-page":"1","article-title":"Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer\u2019s disease","volume":"2021","author":"Arroyo-Garc\u00eda","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2023.114545_bb0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114545_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37703","article-title":"TrpV1 receptor activation rescues neuronal function and network gamma oscillations from A\u03b2-induced impairment in mouse hippocampus in vitro","volume":"7","author":"Balleza-Tapia","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2023.114545_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/alz.037789","article-title":"Synaptic vesicle protein SV2A imaging with [11C]UCB-J as a novel biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"16","author":"Bendlin","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2023.114545_bb0045","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1523\/JNEUROSCI.0425-20.2020","article-title":"Inhibitory Parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial Alzheimer\u2019s disease","volume":"40","author":"Caccavano","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/JAD-160081","article-title":"Short-term effects of rhythmic sensory stimulation in Alzheimer\u2019s disease: an exploratory pilot study","volume":"52","author":"Clements-Cortes","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114545_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","author":"Colom-Cadena","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114545_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2023.114545_bb0070","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.expneurol.2023.114545_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nlm.2013.02.001","article-title":"Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer\u2019s disease in mice","volume":"102","author":"Devi","year":"2013","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.expneurol.2023.114545_bb0080","article-title":"Effects of modulating gamma oscillations via 40Hz transcranial alternating current stimulation (tACS) on tau PET imaging in mild to moderate Alzheimer\u2019s disease","volume":"61","author":"Dhaynaut","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2023.114545_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2023.114545_bb0090","article-title":"Abstract: 15th conference clinical trials Alzheimer\u2019s disease, November 29\u2013December 2, 2022, San Francisco, USA: Posters","volume":"9","author":"Erickson","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114545_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/28179","article-title":"Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro","volume":"394","author":"Fisahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2023.114545_bb0100","doi-asserted-by":"crossref","first-page":"15134","DOI":"10.1523\/JNEUROSCI.4104-10.2010","article-title":"Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus","volume":"30","author":"Guly\u00e1s","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00072","article-title":"Effects of the \u03b3-secretase inhibitor semagacestat on hippocampal neuronal network oscillation","author":"Haj\u00f3s","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.02.001","article-title":"Synaptic vesicle protein 2A as a potential biomarker in synaptopathies","author":"Heurling","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0115","first-page":"1","article-title":"Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease","volume":"25","author":"Hijazi","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2023.114545_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209228","article-title":"Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer\u2019s disease amyloidosis","volume":"14","author":"Hollnagel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2023.114545_bb0125","article-title":"Efficacy of preclinical pharmacological interventions against alterations of neuronal network oscillations in Alzheimer\u2019s disease: a systematic review","volume":"113743","author":"Isla","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0130","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1038\/s41598-020-68845-y","article-title":"Response of spike-wave discharges in aged APP\/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114545_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neurobiolaging.2020.08.013","article-title":"Reduced firing rates of pyramidal cells in the frontal cortex of APP\/PS1 can be restored by acute treatment with levetiracetam","volume":"96","author":"Klee","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114545_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2011-110830","article-title":"Hippocampal GABAergic neurons are susceptible to amyloid-\u03b2 toxicity in vitro and are decreased in number in the alzheimer\u2019s disease TgCRND8 mouse model","volume":"29","author":"Krantic","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114545_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2018.07.009","article-title":"Gamma oscillations in cognitive disorders","author":"Mably","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fnagi.2016.00327","article-title":"Phenotypic alterations in hippocampal NPY- and PV-expressing interneurons in a Presymptomatic transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Mahar","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.02.029","article-title":"Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"Martinez-Losa","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114545_bb0160","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam alters oscillatory connectivity in Alzheimer\u2019s disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114545_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/alz.045476","article-title":"A randomized controlled trial measuring changes in cerebral blood flow after levetiracetam in patients with Alzheimer\u2019s disease","volume":"16","author":"Musaeus","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2023.114545_bb0170","doi-asserted-by":"crossref","DOI":"10.1021\/cn500105p","article-title":"New mouse model of Alzheimer\u2019s","author":"Nilsson","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0180","first-page":"18","article-title":"Optogenetic activation of parvalbumin and somatostatin interneurons selectively restores theta-nested gamma oscillations and oscillation-induced spike timing-dependent long-Term potentiation impaired by amyloid \u03b2 oligomers","author":"Park","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0185","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0190","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/epi.13849","article-title":"A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults","volume":"58","author":"Schoenberg","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2023.114545_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/alz.043198","article-title":"Entrainment of gamma oscillations by auditory chirp stimulation in Alzheimer\u2019s disease patients","volume":"16","author":"Sedghizadeh","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2023.114545_bb0200","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/cns.12144","article-title":"Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe\/PS1dE9 transgenic mice","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2023.114545_bb0205","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1021\/acs.jmedchem.5b00624","article-title":"Novel Levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies","volume":"58","author":"Sola","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2023.114545_bb0210","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.0693-14.2014","article-title":"Inhibitory interneuron progenitor transplantation restores Normal learning and memory in ApoE4 Knock-in mice without or with a accumulation","volume":"34","author":"Tong","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114545_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of Levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2023.114545_bb0220","article-title":"TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer\u2019s Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial","volume":"6","author":"Xing","year":"2020","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:56:22Z","timestamp":1762149382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488623002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":44,"alternative-id":["S0014488623002303"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114545","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose of levetiracetam counteracts amyloid \u03b2-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114545"}}